体外冲击波疗法对鼠模型退变半月板的保护作用
研究在大鼠前交叉韧带切断(ACLT)模型中评估体外冲击波疗法(ESWT)对退变半月板的治疗作用。ESWT+组在ACLT后4周接受单次800次冲击波、能量通量密度0.22 mJ/mm2治疗。结果显示ESWT+组半月板组织病理学评分在ESWT后4周和12周显著低于ESWT-组,CTGF/CCN2和Col2α1 mRNA表达增加,作者认为ESWT可能通过刺激软骨修复因子和诱导2型胶原抑制ACLT诱导的半月板退变。
要点
- ESWT+组半月板组织病理学评分在ESWT后4周和12周显著低于ESWT-组。
- ESWT+组CTGF/CCN2 mRNA在ESWT后24小时增加,Col2α1 mRNA在ESWT后4周增加。
- ESWT+组CTGF/CCN2阳性细胞和Ki-67阳性细胞比例在ESWT后显著高于ESWT-组。
核心结论
- 本研究揭示ESWT可能通过刺激软骨修复因子和诱导2型胶原抑制ACLT诱导的半月板退变。
- 作者认为在大鼠ACLT模型中ESWT可以是保护退变半月板的有效治疗。
研究设计与样本
- 对照实验室研究。
- 12周龄雄性Wistar大鼠随机分为3组(正常组、ESWT-组和ESWT+组),后两组行右膝单侧ACLT。
- ACLT后4周,ESWT+组接受单次800次冲击波、能量通量密度0.22 mJ/mm2治疗。
- ESWT后检查内侧半月板后部组织学变化(每组n=15)。
- ESWT后行实时聚合酶链反应(PCR)(每组n=5)分析CTGF/CCN2、性别决定区Y框蛋白9、血管内皮生长因子α、聚集蛋白聚糖、1型胶原α2和2型胶原α1(Col2α1)表达。
主要发现
- ACLT后4周半月板组织病理学评分显著高于正常组。
- ESWT+组半月板组织病理学评分在ESWT后4周和12周显著低于ESWT-组。
- 实时PCR显示ACLT后4周CTGF/CCN2和Col2α1 mRNA表达降低。
- ESWT+组实时PCR显示CTGF/CCN2 mRNA在ESWT后24小时增加,Col2α1 mRNA在ESWT后4周增加(所有显著数据P<.05)。
- ESWT+组ESWT后CTGF/CCN2阳性细胞和Ki-67阳性细胞比例显著更高。
关键数值与推荐
- ESWT方案:单次800次冲击波,能量通量密度0.22 mJ/mm2。
- 所有显著数据P<.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Loss of meniscal function in association with degenerative changes affects the development and progression of knee osteoarthritis, for which there is currently no effective treatment. Extracorporeal shockwave therapy (ESWT) is an established treatment for musculoskeletal disorders. However, the therapeutic effect of ESWT on meniscal degeneration remains unclear. PURPOSE: To evaluate the therapeutic effect of ESWT on the degenerated meniscus in an anterior cruciate ligament transection (ACLT) model. STUDY DESIGN: Controlled laboratory study. METHODS: Twelve-week-old male Wistar rats were randomly assigned to 3 groups (normal, ESWT-, and ESWT+). Unilateral ACLT of the right knee was performed in the latter 2 groups. At 4 weeks after ACLT, the ESWT+ group received 800 shockwave impulses at an energy flux density of 0.22 mJ/mm2 in a single session. Histological changes were examined in the posterior portion of the medial meniscus after ESWT (n = 15 per group). Real-time polymerase chain reaction (PCR) was performed after ESWT (n = 5 per group) to analyze the expression of connective tissue growth factor/CCN family member 2 (CTGF/CCN2), sex determining region Y-box 9, vascular endothelial growth factor α, aggrecan, collagen type 1 alpha 2, and collagen type 2 alpha 1 (Col2α1). Immunohistochemistry was used to analyze the expression of CTGF/CCN2 and Ki-67 (n = 5 per group) after ESWT. RESULTS: The meniscal histopathological score at 4 weeks after ACLT was significantly higher than that in the normal group, and the score in the ESWT+ group was significantly lower than that in the ESWT- group at 4 and 12 weeks after ESWT. Real-time PCR revealed that the mRNA expression of CTGF/CCN2 and Col2α1 decreased 4 weeks after ACLT. In the ESWT+ group, real-time PCR revealed that the mRNA expression of CTGF/CCN2 increased 24 hours after ESWT, and the expression of Col2α1 increased 4 weeks after ESWT (all significant data were P < .05). The ratio of CTGF/CCN2-positive cells and Ki67-positive cells was significantly higher in the ESWT+ group after ESWT. CONCLUSION: The present study revealed that ESWT might suppress ACLT-induced meniscal degeneration by stimulating cartilage repair factors and inducing collagen type 2. CLINICAL RELEVANCE: ESWT can be an effective treatment to protect the degenerated meniscus in a rat model of ACLT.
引用
- Takase R, Ichinose T, Hashimoto S, et al. Protective Effects of Extracorporeal Shockwave Therapy on the Degenerated Meniscus in a Rat Model. Am J Sports Med. 2024. PMID: 38174366. doi:10.1177/03635465231214697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。